• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Harvey Acquires Hexus to Strengthen Legal Tech Position

chest

Harvey has acquired Hexus to strengthen its position in the legal tech market.

user avatarMohamed Farouk

Harvey's Valuation Soars to $8 Billion Amidst Legal Tech Expansion

chest

Harvey AI has confirmed an impressive valuation of $8 billion following a $160 million funding round led by Andreessen Horowitz.

user avatarBayarjavkhlan Ganbaatar

FLOKI Experiences 12.5% Dip Despite Increased Trading Volume

chest

FLOKI's price has dipped by 12.5% while trading volume has surged, indicating active market participation.

user avatarElias Mukuru

Afghanistan's Crypto Market Declines from Top 20 Ranking

chest

Afghanistan's crypto activity peaked in 2021 at a global ranking of 20 but has significantly declined by 2026, with experts noting a lack of events and regulatory changes.

user avatarMaria Fernandez

Afghanistan's Crypto Sector Faces Stagnation in 2026

chest

In 2026, Afghanistan's crypto sector is marked by stagnation, with no new funding, projects, or leadership emerging.

user avatarKenji Takahashi

Afghanistan Named a Crypto Innovation Hub by New York Times

chest

Afghanistan was recognized as a crypto innovation hub by the New York Times in January 2026, highlighting its unique position in the digital currency sphere despite political challenges.

user avatarDiego Alvarez

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.